Category Archives: COVID-19 Updates

Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations

By Denise Bell | Published March 11, 2021

Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is expanding its manufacturing footprint in Athens, TX where Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in the attractive PTA, Endourology, and Endoscopy markets. The Texas expansion totals 24,000 sq. ft. including […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Comments Off

IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards

By Denise Bell | Published March 1, 2021

Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the ‘Diagnostic and Beyond’ category. Although IONIQ did not win the category, being among the top finalists is a signiicant distinction. Placement was determined by companies receiving the most votes. “We’re on a mission to modernize cancer detection […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®

By Denise Bell | Published March 1, 2021

Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses Co-Diagnostics CoPrimer™ technology, is now available through Walgreens Find Care®, allowing consumers a convenient, non-invasive option for PCR-based COVID-19 testing from their own. Dwight Egan, Co-Diagnostics CEO, stated, “Co-Diagnostics is proud that our technology will be available […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

By Denise Bell | Published March 1, 2021

Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]

Also posted in BioUtah News, Life Sciences Industry News, Press Releases, State News, Utah's Life Sciences Companies | | Leave a comment

2021 BioHive Entrepreneur and Investor Life Sciences Summit BioHive, J.P. Morgan, Pitch Competition, Local, National Investors and More…

By Denise Bell | Published March 1, 2021

ICYMI If you missed the 2021 BioHive Entrepreneur and Investor Life Sciences (E&I) Summit or weren’t able to attend all the sessions, you can access the programming for a limited time. Registered attendees can access recorded sessions free of charge. Not already registered? You can register and access the program for $25. The 2021 E&I […]

Also posted in BioUtah News, Events, Life Sciences Events | | Leave a comment

American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health

By Denise Bell | Published February 12, 2021

RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11. The virtual event brought together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a […]

Also posted in BioUtah News, Industry News, Utah's Life Sciences Companies | | Leave a comment

Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies

By Denise Bell | Published February 12, 2021

Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh website. Following years of scientific research and development, EVŌQ Nano is ready to share its story of next-generation nanotechnology and raise its next round of investment. “We truly are a thought leader in nanotechnology,” said CEO Scott […]

Also posted in BioUtah News, Industry News, Utah's Life Sciences Companies | | Leave a comment

Novel Embolic Device Used for Arterial and Venous Tumor Treatments

By Denise Bell | Published February 5, 2021

Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term […]

Also posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE

By Denise Bell | Published January 29, 2021

Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address – a live broadcast from the City Council Chambers in which she reflected on 2020 and outlined her plan for the City in 2021. The Mayor noted that “we are striving to make our city better through change; […]

Also posted in BioUtah News, Economic Developments, State News, Utah's Life Sciences Companies | | Leave a comment

Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

By Denise Bell | Published January 29, 2021

Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of Dentistry for a study on using saliva in early lung cancer detection and analysis. Spectrum has funded a study that aims to recruit 50 patients with lung cancer and seeks to validate saliva’s tumor-specific ctDNA detection sensitivity […]

Also posted in BioUtah News, State News, Utah's Life Sciences Companies | | Leave a comment

Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use

By Denise Bell | Published January 22, 2021

Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood clots from patients with deep vein thrombosis (DVT). The system is Utah born, designed, engineered, patent prosecuted, and manufactured. “The Control 11 French Mechanical Thrombectomy System can remove large clots,” said Shawn Fojtik, President of Control […]

Also posted in Industry News, Policy News, Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes

By Denise Bell | Published January 22, 2021

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0184, an activin receptor-like kinase 2 (ALK2) and ALK5 inhibitor, for the treatment of anemia in adult patients with low or intermediate risk myelodysplastic syndromes (MDS). “The management of […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Category Archives: COVID-19 Updates

A Special Thanks To Our Elite Members